Register to Vote: Rock the Vote, powered by Credo Mobile

HOME

ABOUT US

OUR ISSUES

Federal Budget

Information & Access

Nonprofit Advocacy

Regulatory Policy


PRESS ROOM

ACTION CENTER

PUBLICATIONS

THE WATCHER

OUR BLOGS


SIGN UP

Receive news, updates, and alerts!

DONATE

Help support our work


OTHER SITES

FedSpending.org

RTK NET

NPAction

Working Group on Community Right-to-Know

Citizens for Sensible Safeguards

Open the Government

OMB Watch Logo
August 8, 2005 Vol.6, No.16:   


Published: 08/08/2005

Printable Version
Email to a Friend


Learn more about what constitutes lobbying here, courtesy of NPAction.org.


High Court Nominee Admits Lobbying OMB, FDA

Supreme Court nominee John G. Roberts, Jr. conceded that he omitted records of lobbying the White House Office of Management and Budget (OMB) and U.S. Food and Drug Administration (FDA) from his other public disclosures, after Newsday uncovered the lobbying activities.

As an attorney for the Cosmetics, Toiletry and Fragrance Association, Roberts lobbied against proposed labeling regulations for sunscreen products by threatening litigation. After Newsday broke the story that these contacts were omitted from his previous disclosures to the Senate, Roberts argued that he had not included these contacts because he had considered the discussion of litigation as a legal task rather than a lobbying task.

Newsday notes that Roberts worked for CTFA longer than mentioned in either the previous disclosures or the follow-up letter Roberts submitted in response to the Newsday investigation:

The group's executive, Edward Kavanaugh, said he had hired Roberts for two tasks, to draft a lawsuit based on First Amendment and commercial free speech issues, and to work on the labeling of cosmetics like lipstick treated as over-the-counter drugs. But he did not return calls seeking clarification on when he hired Roberts.

An FDA record shows that on Jan. 4, 2000, Roberts and the cosmetic group's general counsel met with FDA officials to discuss a final rule for labeling over-the-counter drug products. The FDA calendar shows that in October 2001 Roberts and cosmetic association officials, including Kavanaugh, met with FDA lawyers about sunscreen labeling.

Hogan & Hartson did not register as a lobbyist for the cosmetics group until March 20, 2001. It filed that registration and a report on the first six months of 2001 in August 2001, and noted Roberts had met with [officials at the White House Office of Management and Budget (OMB)].

Roberts' meeting with OMB’s Office of Information and Regulatory Affairs back in 2001 was recorded in a handwritten meeting log. OIRA now posts these meetings online. OMB Watch has an archive of meeting logs that OIRA did not post electronically.